Kyle Gano, Chief Business Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,264 shares at $107.41 ($458K) on 2023-08-21, disclosed to the SEC on 2023-08-23.
Scheduled sale ($458k) by Chief Business Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.41 | 2,132 | $229K | 50.0% |
| 2 | $107.41 | 2,132 | $229K | 50.0% |
| Total | $107.41 avg | 4,264 | $458K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $598K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $471K | — | Filing → |